Seagen
SGEN
$228.74
Share price
-0.07%
Change (1 day)
68.92%
Change (1 year)
Categories
Market capitalization of Seagen (SGEN)
Market cap: $43.15 Billion
As of April 2024 Seagen has a market cap of $43.15 Billion. This makes Seagen the world's 435th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Seagen from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $43.15 B | 0% |
| 2023 | $43.15 B | 80.87% |
| 2022 | $23.85 B | -15.6% |
| 2021 | $28.26 B | -9.82% |
| 2020 | $31.34 B | 59.52% |
| 2019 | $19.65 B | 116.42% |
| 2018 | $9.08 B | 17.93% |
| 2017 | $7.70 B | 3.08% |
| 2016 | $7.46 B | 19.16% |
| 2015 | $6.26 B | 57.37% |
| 2014 | $3.98 B | -18.56% |
| 2013 | $4.89 B | 76.34% |
| 2012 | $2.77 B | 44.28% |
| 2011 | $1.92 B | 26.56% |
| 2010 | $1.51 B | 48.69% |
| 2009 | $1.02 B | 33.48% |
| 2008 | $0.76 B | -0.57% |
| 2007 | $0.76 B | 183.02% |
| 2006 | $0.27 B | 35.97% |
| 2005 | $0.20 B | -27.04% |
| 2004 | $0.27 B | -0.24% |
| 2003 | $0.27 B | 188.84% |
| 2002 | $95.14 M | -43.07% |
| 2001 | $0.16 B |
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $143.97 B | 233.61% | 🇺🇸 USA |
 AbbVie ABBV | $296.84 B | 587.87% | 🇺🇸 USA |
 Biogen BIIB | $29.08 B | -32.60% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $90.65 B | 110.07% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $83.48 B | 93.46% | 🇬🇧 UK |
 Spectrum Pharmaceuticals
SPPI | $0.21 B | -99.51% | 🇺🇸 USA |
 ImmunoGen
IMGN | $8.72 B | -79.78% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $2.43 B | -94.36% | 🇺🇸 USA |